Literature DB >> 28104450

Polymerases of paramyxoviruses and pneumoviruses.

Rachel Fearns1, Richard K Plemper2.   

Abstract

The paramyxo- and pneumoviruses are members of the order Mononegavirales, a group of viruses with non-segmented, negative strand RNA genomes. The polymerases of these viruses are multi-functional complexes, capable of transcribing subgenomic capped and polyadenylated mRNAs and replicating the genome. Although there is no native structure available for any complete paramyxo- or pneumovirus polymerase, functional and structural studies of a fragment of a pneumovirus polymerase protein and mutation analyses and resistance profiling of small-molecule inhibitors have generated a wealth of mechanistic information. This review integrates these data with the structure of a related polymerase, identifying similarities, differences, gaps in knowledge, and avenues for antiviral drug development.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Capping; Inhibitor; Mononegavirales; Paramyxovirus; Pneumovirus; Polymerase

Mesh:

Substances:

Year:  2017        PMID: 28104450      PMCID: PMC5476513          DOI: 10.1016/j.virusres.2017.01.008

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  136 in total

1.  In silico identification, structure prediction and phylogenetic analysis of the 2'-O-ribose (cap 1) methyltransferase domain in the large structural protein of ssRNA negative-strand viruses.

Authors:  Janusz M Bujnicki; Leszek Rychlewski
Journal:  Protein Eng       Date:  2002-02

2.  Plus and minus strand leader RNAs in negative strand virus-infected cells.

Authors:  M Leppert; L Rittenhouse; J Perrault; D F Summers; D Kolakofsky
Journal:  Cell       Date:  1979-11       Impact factor: 41.582

3.  The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif (GNNNNN)3 is essential for replication.

Authors:  C Tapparel; D Maurice; L Roux
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus.

Authors:  Tomoaki Ogino; Amiya K Banerjee
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

5.  The first two nucleotides of the respiratory syncytial virus antigenome RNA replication product can be selected independently of the promoter terminus.

Authors:  Sarah L Noton; Rachel Fearns
Journal:  RNA       Date:  2011-08-30       Impact factor: 4.942

6.  Human parainfluenza virus type 2 L protein regions required for interaction with other viral proteins and mRNA capping.

Authors:  Machiko Nishio; Masato Tsurudome; Dominique Garcin; Hiroshi Komada; Morihiro Ito; Philippe Le Mercier; Tetsuya Nosaka; Daniel Kolakofsky
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

7.  Model for polymerase access to the overlapped L gene of respiratory syncytial virus.

Authors:  R Fearns; P L Collins
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

8.  Cis-acting elements in the antigenomic promoter of Nipah virus.

Authors:  Pramila Walpita; Clarence J Peters
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

Review 9.  Synergizing vaccinations with therapeutics for measles eradication.

Authors:  Richard K Plemper; Anthea L Hammond
Journal:  Expert Opin Drug Discov       Date:  2013-12-05       Impact factor: 6.098

10.  Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatment.

Authors:  Mitsuyasu Nakamura; Hidetsugu Saito; Masanori Ikeda; Shinichiro Tada; Naoki Kumagai; Nobuyuki Kato; Kunitada Shimotohno; Toshifumi Hibi
Journal:  J Med Virol       Date:  2008-04       Impact factor: 2.327

View more
  33 in total

1.  Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons.

Authors:  Wenbin Wang; Xudong Chang; Wei Yao; Ning Wei; Na Huo; Yanhong Wang; Qiaolin Wei; Haijin Liu; Xinglong Wang; Shuxia Zhang; Zengqi Yang; Sa Xiao
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

2.  The Unstructured Paramyxovirus Nucleocapsid Protein Tail Domain Modulates Viral Pathogenesis through Regulation of Transcriptase Activity.

Authors:  Vidhi D Thakkar; Robert M Cox; Bevan Sawatsky; Renata da Fontoura Budaszewski; Julien Sourimant; Katrin Wabbel; Negar Makhsous; Alexander L Greninger; Veronika von Messling; Richard K Plemper
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

3.  Consequences of Phosphorylation in a Mononegavirales Polymerase-Cofactor System.

Authors:  Joseph R Gould; Shihong Qiu; Qiao Shang; Terje Dokland; Tomoaki Ogino; Chad M Petit; Todd J Green
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 4.  Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses.

Authors:  Venice Du Pont; Richard K Plemper; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2019-02-10       Impact factor: 7.090

5.  The respiratory syncytial virus polymerase can perform RNA synthesis with modified primers and nucleotide analogs.

Authors:  Barbara Ludeke; Rachel Fearns
Journal:  Virology       Date:  2019-11-06       Impact factor: 3.616

6.  Respiratory Syncytial Virus Phosphoprotein Residue S156 Plays a Role in Regulating Genome Transcription and Replication.

Authors:  Ashley C Beavis; Kim C Tran; Enrico R Barrozo; Shannon I Phan; Michael N Teng; Biao He
Journal:  J Virol       Date:  2021-10-06       Impact factor: 5.103

7.  4'-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication.

Authors:  Julien Sourimant; Carolin M Lieber; Megha Aggarwal; Robert M Cox; Josef D Wolf; Jeong-Joong Yoon; Mart Toots; Chengin Ye; Zachary Sticher; Alexander A Kolykhalov; Luis Martinez-Sobrido; Gregory R Bluemling; Michael G Natchus; George R Painter; Richard K Plemper
Journal:  Science       Date:  2021-12-02       Impact factor: 63.714

Review 8.  Measles Resurgence and Drug Development.

Authors:  Richard K Plemper
Journal:  Curr Opin Virol       Date:  2020-04-01       Impact factor: 7.090

9.  Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro.

Authors:  Yuzhen Gao; Jingjing Cao; Pan Xing; Ralf Altmeyer; Youming Zhang
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

Review 10.  Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene.

Authors:  Jordan Douglas; Alexei J Drummond; Richard L Kingston
Journal:  Virus Evol       Date:  2021-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.